Published on 5 Mar 2024 on GuruFocus.com via Yahoo Finance
Xiangyang Ni, President of Greater China at Viatris Inc (NASDAQ:VTRS), executed a sale of 21,532 shares in the company on March 4, 2024, according to a recent SEC filing. The transaction was disclosed in a Form 4 filing with the Securities and Exchange Commission.
Viatris Inc is a global healthcare company that provides access to medicines, sustainable operations, and community health programs. The company's mission is to empower people worldwide to live healthier at every stage of life by providing a range of products including branded, generic, complex generics, biosimilars, over-the-counter remedies, and more.
Warning! GuruFocus has detected 8 Warning Signs with VTRS.